-
Nu.Q® Technology
Our technology detects characteristic epigenetic changes in nucleosomes that occur from the earliest stages of cancer, sepsis and other diseases.
-
- Our Tests
- Human Health
-
Nu.Q® NETs
Nu.Q® NETs is a groundbreaking CE-marked diagnostic solution that clinicians can use to detect NETosis.
-
Nu.Q® Discover
Buy our Nu.Q® Discover H3.1 Research Use Only Assay
- Animal Health
-
Nu.Q® Vet Cancer Test
Nu.Q® Vet Cancer Test is an affordable, accessible blood test that detects cancer in dogs.

Early detection of stage I/II Lung Cancer by immunoassay of crosslinked plasma cell free nucleosomes
- Share
- Tweet
- Share on Facebook
- Share


Paper titled: Early detection of stage I/II Lung Cancer by immunoassay of crosslinked plasma cell free nucleosomes
J. MICALLEF, D. PAMART, B. CUVELIER, G. ROMMELAERE and M. HERZOG – R&D Department, Belgian Volition SRL, Isnes, Belgium
Presented at ELCC 2025
Related Articles
- Share
- Tweet
- Share on Facebook
- Share
Subscribe for Volition product updates.
Or, click here for Investor Updates and press releases.
"*" indicates required fields